Co-Diagnostics's PP&E is $3.7M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CODX shows a PP&E of $3.7M. That compares with $4.3M in the prior-year period — down 13.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CODX's PP&E is now $3.7M (was $4.3M) — a 13.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Co-Diagnostics is outperforming or lagging.
Tracking CODX's property, plant & equipment over time shows whether Co-Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7M That compares with $4.3M in the prior-year period — down 13.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this property, plant & equipment page, Stockcircle has Co-Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PP&E (currently $3.7M) with ownership activity and broader fundamentals.
Co-Diagnostics's PP&E is $3.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.